Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,182.9
3.5 (0.11%)

 

  • STI Straits Times Index
    3,182.9
    3.5 (0.11%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,599.6
    1.3 (0.08%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,900.8
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,416.7
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,729.2
    108.2 (0.37%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,050.3
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 207.6M
  • Value: 130.1M
  • Rise: 96
  • Fall: 56
  • Unch: 618

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.199+0.002
P5 Capital0.039+0.001
Jiutian Chemical0.100-0.001
Rex Intl0.184+0.001
Anchor Resources0.031-
Oceanus^0.041-0.001
Ntegrator Intl0.014-
MM2 Asia0.058-0.001
CWX Global0.004-0.001
CromwellReit EUR0.470+0.010

World Indices

World Indices
Name Last Change
Nasdaq 13,857.8 -138.3
HSI 28,780.7 -120.1
HSCEI 10,936.4 -62.9
Jakarta 6,050.3
Nikkei 225 29,715.4 +94.4
SSE Comp 3,400.8 -15.9
Shanghai A 3,564.6 -16.7
Shanghai B 246.0
KOSPI 3,198.0 +15.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

IM CANNABIS CORP IM CANNABIS CORP
Updated on 14 Apr 2021 (End of trading day)
Last (USD): 6.040 Change: -0.300 High: 6.240 Remarks: -
Change (%): -4.73 Low: 5.750
Open 6.200 Yesterday's Close 6.34
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 43,819 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.10888 Trailing EPS (USD) e -0.10888 NAV (USD) b 0.4177
PE a - Trailing PE f - Price / NAV b 14.4601
Dividend (USD) d - Cash In Hand (USD) g 0.1447 Issued & Paid-up Shares c 50,473,100
Dividend Yield (%) d - Price / Cash In Hand g 41.742 Treasury Shares h -
Market Cap (M) 304.858 Enterprise Value (M) 299.911
Piotroski F Score 1 Exchange Code IMCC Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 38.8
Sector & Industry Health Technology - Pharmaceuticals: Other
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 26 Mar 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 01 Mar 2021.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference IM CANNABIS CORP NASDAQ 304.858 - - 14.4601 -
Industry Pharmaceuticals: Other NASDAQ 1,707.446 104.122 102.761 4.8020 -
Local Peer HORIZON THERAPEUTICS PLC NASDAQ 20,491.567 52.570 52.570 5.0906 -
Local Peer ARGENX SE SPON ADR EACH REP 1 ORD SHS NASDAQ 13,894.240 - - 8.3230 -
Local Peer ICON PLC NASDAQ 10,453.627 31.455 31.455 5.6499 -
Local Peer JAZZ PHARMACEUTICALS PLC NASDAQ 9,370.857 39.272 39.272 2.5605 -
Local Peer UNITED THERAPEUTICS CORP NASDAQ 8,877.679 17.245 17.245 2.6148 -
Local Peer GW PHARMACEUTICALS ADS EA REPR 12 ORD GBP0.00 NASDAQ 6,885.764 - - 9.2914 -
Local Peer SAGE THERAPEUTICS INC NASDAQ 4,417.758 7.289 7.289 2.1318 -
Local Peer PACIRA BIOSCIENCES INC NASDAQ 3,045.443 20.928 20.928 4.9145 -
Local Peer REVOLUTION MEDICINES INC NASDAQ 2,919.918 - - 6.1513 -
Local Peer CORCEPT THERAPEUTICS INC NASDAQ 2,692.310 25.396 25.397 5.1445 -
Local Peer AMARIN CORP ADR EACH REP 1 ORD GBP0.50 NASDAQ 2,011.475 - - 3.2056 -
Local Peer REVANCE THERAPEUTICS INC NASDAQ 2,010.856 - - 5.3725 -
Other Local Peers AXSOME THERAPEUTICS INC (NASDAQ), MADRIGAL PHARMACEUTICALS INC (NASDAQ), IRONWOOD PHARMACEUTICALS INC (NASDAQ), SUPERNUS PHARMACEUTICALS INC (NASDAQ), CASSAVA SCIENCES INC (NASDAQ), ENDO INTERNATIONAL PLC (NASDAQ), ACLARIS THERAPEUTICS INC (NASDAQ), THERAVANCE BIOPHARMA INC (NASDAQ), INNOVIVA INC (NASDAQ), ZOGENIX INC (NASDAQ), AERIE PHARMACEUTICALS INC (NASDAQ), AMPHASTAR PHARMACEUTICALS INC (NASDAQ), COLLEGIUM PHARMACEUTICAL INC (NASDAQ), INTERCEPT PHARMACEUTICALS INC (NASDAQ), INTERSECT ENT INC (NASDAQ), ALBIREO PHARMA INC (NASDAQ), ANIKA THERAPEUTICS INC (NASDAQ), EAGLE PHARMACEUTICALS INC (NASDAQ), MARINUS PHARMACEUTICALS INC (NASDAQ), CATALYST PHARMACEUTICALS INC (NASDAQ), VERONA PHARMA SPON ADR EACH REP 8 ORD SHS (NASDAQ), ANI PHARMACEUTICALS INC (NASDAQ), MEI PHARMA INC (NASDAQ), TONIX PHARMACEUTICALS HLDG CORP (NASDAQ), BIODELIVERY SCIENCES INTERNATIONAL (NASDAQ), ORAMED PHARMACEUTICALS INC (NASDAQ), KEMPHARM INC (NASDAQ), CERECOR INC (NASDAQ), PLX PHARMA INC (NASDAQ), CTI BIOPHARMA CORP (NASDAQ), GT BIOPHARMA INC (NASDAQ), ADAMAS PHARMACEUTICALS INC (NASDAQ), ZYNERBA PHARMACEUTICALS INC (NASDAQ), ASSEMBLY BIOSCIENCES INC (NASDAQ), AGILE THERAPEUTICS INC (NASDAQ), SCYNEXIS INC (NASDAQ), BIOPHYTIS SPON ADS EACH REP 10 ORD SHS (NASDAQ), ACELRX PHARMACEUTICALS INC (NASDAQ), CLEVER LEAVES HOLDINGS INC (NASDAQ), LIPOCINE INC (NASDAQ), HEPION PHARMACEUTICALS INC (NASDAQ), SCOPUS BIOPHARMA INC (NASDAQ), NATURAL ALTERNATIVES INTERNATIONAL (NASDAQ), BIOLINE RX LTD SPON ADS EACH REPR 15 ORD SHS (NASDAQ), ACASTI PHARMA INC (NASDAQ), REGULUS THERAPEUTICS INC (NASDAQ), GALMED PHARMACEUTICALS LTD (NASDAQ), QUALIGEN THERAPEUTICS INC (NASDAQ), EVOKE PHARMA INC (NASDAQ), ENVERIC BIOSCIENCES INC (NASDAQ), HAPPINESS BIOTECH GROUP LTD (NASDAQ), CUMBERLAND PHARMACEUTICALS INC (NASDAQ), EYEGATE PHARMACEUTICALS INC (NASDAQ), INTEC PHARMA LTD (NASDAQ), SONOMA PHARMACEUTICALS INC (NASDAQ)
Global Peer CATALENT INC NYSE 18,709.650 108.148 64.074 5.4144 -
Global Peer FOSUN PHARMA HKEx 90,982.985 22.105 22.105 2.0774 -
Global Peer BAUSCH HEALTH COMPANIES INC NYSE 10,762.302 - - 20.1170 -
Global Peer PERRIGO COMPANY PLC NYSE 5,393.435 - - 0.9537 2.221
Global Peer Kalbe Farma Tbk. IDX 70,075,022.875 25.638 25.638 4.0260 -
Global Peer LIVZON PHARMA HKEx 32,727.461 16.983 16.983 2.2799 4.277
Global Peer BELLRING BRANDS INC NYSE 3,286.234 139.843 129.891 -1.3147 -
Global Peer SIHUAN PHARM HKEx 24,326.798 43.077 43.077 2.2325 0.665
Global Peer LUYE PHARMA HKEx 18,055.385 22.740 22.740 1.9298 -
Global Peer PRESTIGE CONSUMER HEALTHCARE INC NYSE 2,184.577 15.354 13.143 1.6510 -
Other Global Peers BLACKMORES LTD (ASX), CLINUVEL PHARMACEUTICALS LTD (ASX), FUDANZHANGJIANG (HKEx), TONG REN TANG (HKEx), MEGA (SET), HEC PHARM (HKEx), HBM HOLDINGS-B (HKEx), Tianjin ZX USD (SGX), OCI INTL (HKEx), Indofarma Tbk. (IDX), CONSUN PHARMA (HKEx), SHANDONG XINHUA (HKEx), DOD (SET), GOLDEN THROAT (HKEx), AMPIO PHARMACEUTICALS INC (NYSE American), ANTISENSE THERAPEUTICS (ASX), ALTHEA GROUP HOLDINGS LTD (ASX), LANSEN PHARMA (HKEx), YSPSAH (Bursa), BOTANIX PHARMACEUTICALS LTD (ASX), C HEALTH GP (HKEx), ISORAY INC (NYSE American), TIANDA PHARMA (HKEx), IDT AUSTRALIA LIMITED (ASX), VITA LIFE SCIENCES LIMITED (ASX), Pyridam Farma Tbk (IDX), PHARMAUST LIMITED (ASX), NUTRITIONAL GROWTH SOLUTIONS LTD (ASX), CRONOS AUSTRALIA LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.120
-15.64 %
10 Days --1.085
-15.23 %
20 Days --1.960
-24.50 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 6.220 - 11.630 Change From 1 Year Low -0.180 % Change From 1 Year Low (%) -2.90
Change From 1 Year High -5.590 % Change From 1 Year High (%) -48.07
2 Years Range 6.220 - 11.630 Change From 2 Years Low -0.180 % Change From 2 Years Low (%) -2.90
Change From 2 Years High -5.590 % Change From 2 Years High (%) -48.07
5 Years Range 6.220 - 11.630 Change From 5 Years Low -0.180 % Change From 5 Years Low (%) -2.90
Change From 5 Years High -5.590 % Change From 5 Years High (%) -48.07
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

IM Cannabis Corp. engages in the production and sale of medical cannabis products. It offers dry flower products and cannabis oil products under IMC brand. The company was founded on March 7, 1980 and is headquartered in Glil Yam, Israel.

Historical Price Data

Date Open High Low Close Volume VWAP
13 Apr 2021 6.500 6.500 6.100 6.340 18,927 -
12 Apr 2021 6.610 6.624 6.220 6.260 28,764 -
09 Apr 2021 6.820 7.057 6.520 6.610 13,804 -
08 Apr 2021 6.810 7.147 6.680 6.820 18,260 -
07 Apr 2021 7.300 7.300 6.780 7.160 14,592 -
06 Apr 2021 7.400 7.580 7.223 7.230 17,046 -
05 Apr 2021 8.070 8.070 7.400 7.600 28,094 -
01 Apr 2021 7.800 7.800 7.130 7.510 83,407 -
31 Mar 2021 7.080 7.240 6.520 7.125 16,494 -
30 Mar 2021 7.740 7.740 7.050 7.120 19,309 -
29 Mar 2021 7.660 8.000 7.200 7.500 30,268 -
26 Mar 2021 7.200 7.710 7.150 7.160 32,454 -
25 Mar 2021 7.740 7.740 6.950 7.040 36,935 -
24 Mar 2021 7.550 7.900 7.275 7.740 17,128 -
23 Mar 2021 7.960 7.960 7.620 7.870 14,065 -
22 Mar 2021 8.400 8.400 7.990 8.000 17,069 -
19 Mar 2021 7.680 8.020 7.680 8.020 23,853 -
18 Mar 2021 8.070 8.070 7.750 8.000 66,836 -
17 Mar 2021 8.130 8.130 7.610 8.000 21,121 -
16 Mar 2021 8.100 8.300 7.600 8.060 20,455 -
15 Mar 2021 8.400 8.400 7.750 8.100 32,968 -
12 Mar 2021 8.100 8.361 7.950 8.000 38,247 -
Summary
Current 2 Weeks
(30 Mar 2021 to 13 Apr 2021)
7.740 8.070 6.100 6.340 258,697 -
Previous 2 Weeks
(16 Mar 2021 to 29 Mar 2021)
8.100 8.300 6.100 7.500 280,184 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.